Piper Jaffray Lowers PT on Human Genome Sciences to $15

Symbols: HGSI
Share

Piper Jaffray has lowered the price target on Human Genome Sciences (NASDAQ: HGSI) from $18 to $15 and maintains its Overweight rating.


 
 
< Previous
Citigroup Upgrades Valspar to Buy, PT Raised to $40
Next >
Jefferies Lowers PT on US Steel to $25
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust